{"transactions":[{"id":687129,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-14T21:40:33.000Z","date":"2026-08-14","kind":"grant","planned":false,"acquired":true,"shares":13192,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units which vest in accordance with the applicable grant agreement."}],"balance_after":62863,"source":{"system":"sec-edgar","filing":"0001724161-26-000008","document":"wk-form4_1786743631.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000172416126000008/wk-form4_1786743631.xml","form_type":"4"}},{"id":782954,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T12:22:31.000Z","date":"2026-05-11","kind":"purchase","planned":false,"acquired":true,"shares":31050,"price":16.149,"value":501426.45,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.13 to $16.15, inclusive. The reporting person undertakes to provide to Caris Life Sciences, Inc., any security holder of Caris Life Sciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote"}],"balance_after":49671,"source":{"system":"sec-edgar","filing":"0001724161-26-000005","document":"wk-form4_1778588549.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000172416126000005/wk-form4_1778588549.xml","form_type":"4"}},{"id":877754,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-27T23:09:21.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":2492,"price":20.06,"value":49989.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued in lieu of cash compensation for 2025 board retainer fees. Number of shares determined by dividing the cash retainer earned by the ten trading day average of the daily volume weighted average price per share through and including February 25, 2026."}],"balance_after":18621,"source":{"system":"sec-edgar","filing":"0001724161-26-000002","document":"wk-form4_1772233759.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000172416126000002/wk-form4_1772233759.xml","form_type":"4"}},{"id":1482172,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-12T22:00:09.000Z","date":"2024-06-11","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.11,"value":11100.0,"ownership":{"direct":true},"balance_after":151159,"source":{"system":"sec-edgar","filing":"0001104659-24-070931","document":"tm2417085-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465924070931/tm2417085-1_4seq1.xml","form_type":"4"}},{"id":1500531,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-29T00:01:43.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":81225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for these derivative securities."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options that (1) vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting, and (2) were granted on the date of the Issuer's 2024 Annual Meeting of Stockholders in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy."}],"balance_after":81225,"derivative":{"exercise_price":1.01,"expiration_date":"2034-05-23","underlying":"Common Stock","underlying_shares":81225},"source":{"system":"sec-edgar","filing":"0001104659-24-065700","document":"tm2415689-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465924065700/tm2415689-4_4seq1.xml","form_type":"4"}},{"id":1500530,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-29T00:01:43.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":53750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that (1) vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting, and (2) were granted on the date of the Issuer's 2024 Annual Meeting of Stockholders in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy."}],"balance_after":141159,"source":{"system":"sec-edgar","filing":"0001104659-24-065700","document":"tm2415689-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465924065700/tm2415689-4_4seq1.xml","form_type":"4"}},{"id":1818001,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-08-02T22:45:17.000Z","date":"2023-07-31","kind":"grant","planned":false,"acquired":true,"shares":5005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"These derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for these derivative securities."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Stock options were granted in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy on the date the Issuer appointed the Reporting Person to serve on its Board of Directors in accordance with the Merger Agreement. One-third of these stock options are scheduled to vest on each of July 31, 2024, 2025 and 2026, assuming continued service through the applicable vesting date."}],"balance_after":5005,"derivative":{"exercise_price":5.69,"expiration_date":"2033-07-31","underlying":"Common Stock","underlying_shares":5005},"source":{"system":"sec-edgar","filing":"0001104659-23-086925","document":"tm2322708-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465923086925/tm2322708-2_4seq1.xml","form_type":"4"}},{"id":1818000,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-02T22:45:17.000Z","date":"2023-07-31","kind":"grant","planned":false,"acquired":true,"shares":34767,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Restricted stock units were granted in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy on the date the Issuer appointed the Reporting Person to serve on its Board of Directors in accordance with the Merger Agreement. One-third of these restricted stock units are scheduled to vest on each of July 31, 2024, 2025 and 2026, assuming continued service through the applicable vesting date."}],"balance_after":87409,"source":{"system":"sec-edgar","filing":"0001104659-23-086925","document":"tm2322708-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465923086925/tm2322708-2_4seq1.xml","form_type":"4"}},{"id":1817999,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-02T22:45:17.000Z","date":"2023-07-31","kind":"grant","planned":false,"acquired":true,"shares":52642,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 31, 2023, pursuant to the terms of an Agreement and Plan of Merger, dated as of April 24, 2023 (the \"Merger Agreement\"), by and among the Issuer, Spectrum Pharmaceuticals, Inc. (\"Spectrum\") and Spade Merger Sub 1, Inc. (\"Merger Sub\"), Merger Sub merged with and into Spectrum, with Spectrum continuing as the surviving corporation and as a wholly owned subsidiary of the Issuer (the \"Merger\"). At the effective time of the Merger, each share of Spectrum common stock issued and outstanding immediately prior to the effective time automatically converted into (i) 0.1783 of a newly issued share of the Issuer's Common Stock, without interest, plus the right, if any, to receive cash in lieu of fractional shares, and (ii) one non-tradeable contingent value right (\"CVR\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The CVRs represent contractual, contingent rights to receive milestone payments in the form of future conditional payments worth up to an aggregate maximum amount of $0.20, which amount is settleable in cash, additional shares of the Issuer's Common Stock or a combination of cash and additional shares of Common Stock, at the Issuer's sole discretion, upon the achievement of certain sales milestones related to Spectrum's product ROLVEDON. The minimum payment on each CVR is zero and the maximum payment is $0.20."}],"balance_after":52642,"source":{"system":"sec-edgar","filing":"0001104659-23-086925","document":"tm2322708-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465923086925/tm2322708-2_4seq1.xml","form_type":"4"}},{"id":1819763,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-01T17:05:42.000Z","date":"2023-07-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Stock options of the Issuer (the \"Company Options\") were canceled in the merger and (i) if the Company Option had an exercise price less than the Upfront Consideration, it was exchanged for (1) common stock of the Acquiror with a value equal to the quotient of (A) the product of (x) the total number of common stock of Issuer underlying the Company Option multiplied by (y) the excess, if any, of the value of the Upfront Consideration over the exercise price of such Company Option, divided by (B) the average of the daily volume-weighted average price per share of the common stock of Acquiror calculated based on the ten (10) consecutive trading days ending two trading days prior to the date of the Merger Agreement and (2) a number of CVRs equal to the number of shares of common stock of the Issuer underlying such Company Option, (ii) if the Company Option had an exercise price equal to or greater than the Upfront Consideration and less than the Merger Consideration,"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(Continued from Footnote 2) it was exchanged for a number of CVRs equal to the number of common stock of the Issuer underlying such Company Option (reduced by the amount that the exercise price exceeds the Upfront Consideration) and (iii) if the Company Option had an exercise price equal to or greater than the Merger Consideration, it was canceled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options of the Issuer (the \"Company Options\") were canceled in the merger and (i) if the Company Option had an exercise price less than the Upfront Consideration, it was exchanged for (1) common stock of the Acquiror with a value equal to the quotient of (A) the product of (x) the total number of common stock of Issuer underlying the Company Option multiplied by (y) the excess, if any, of the value of the Upfront Consideration over the exercise price of such Company Option, divided by (B) the average of the daily volume-weighted average price per share of the common stock of Acquiror calculated based on the ten (10) consecutive trading days ending two trading days prior to the date of the Merger Agreement and (2) a number of CVRs equal to the number of shares of common stock of the Issuer underlying such Company Option, (ii) if the Company Option had an exercise price equal to or greater than the Upfront Consideration and less than the Merger Consideration,"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"(Continued from Footnote 2) it was exchanged for a number of CVRs equal to the number of common stock of the Issuer underlying such Company Option (reduced by the amount that the exercise price exceeds the Upfront Consideration) and (iii) if the Company Option had an exercise price equal to or greater than the Merger Consideration, it was canceled for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Stock options of the Issuer (the \"Company Options\") were canceled in the merger and (i) if the Company Option had an exercise price less than the Upfront Consideration, it was exchanged for (1) common stock of the Acquiror with a value equal to the quotient of (A) the product of (x) the total number of common stock of Issuer underlying the Company Option multiplied by (y) the excess, if any, of the value of the Upfront Consideration over the exercise price of such Company Option, divided by (B) the average of the daily volume-weighted average price per share of the common stock of Acquiror calculated based on the ten (10) consecutive trading days ending two trading days prior to the date of the Merger Agreement and (2) a number of CVRs equal to the number of shares of common stock of the Issuer underlying such Company Option, (ii) if the Company Option had an exercise price equal to or greater than the Upfront Consideration and less than the Merger Consideration,"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"(Continued from Footnote 2) it was exchanged for a number of CVRs equal to the number of common stock of the Issuer underlying such Company Option (reduced by the amount that the exercise price exceeds the Upfront Consideration) and (iii) if the Company Option had an exercise price equal to or greater than the Merger Consideration, it was canceled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":1.13,"underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000899243-23-017668","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000089924323017668/doc4.xml","form_type":"4"}},{"id":1819762,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2023-08-01T17:05:42.000Z","date":"2023-07-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":295244,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of the Issuer disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of April 24, 2023, by and among the Issuer, Assertio Holdings, Inc., a Delaware corporation (\"Acquiror\"), and Spade Merger Sub 1, Inc., a Delaware corporation and a wholly owned subsidiary of Acquiror, in exchange for consideration of (a) 0.1783 of a share of the common stock of Acquiror and cash in lieu of fractional shares (the \"Upfront Consideration\") and (b) a contingent value right (\"CVR\") to receive up to an additional $0.20 per common share (subject to adjustment), payable in cash or common stock of Acquiror at the election of Acquiror, upon the achievement of certain milestones, (the Upfront Consideration plus one CVR, collectively, the \"Merger Consideration\") on the effective date of the merger."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-017668","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000089924323017668/doc4.xml","form_type":"4"}},{"id":2099208,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2022-12-02T20:17:57.000Z","date":"2022-11-30","kind":"purchase","acquired":true,"shares":50000,"price":0.45,"value":22500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices that when rounded to the nearest cent were equal to $0.45. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Excludes 25,000 restricted stock units granted on August 31, 2022."}],"balance_after":270244,"source":{"system":"sec-edgar","filing":"0000899243-22-037526","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000089924322037526/doc4.xml","form_type":"4"}},{"id":2131341,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2022-10-27T18:35:19.000Z","date":"2022-10-27","kind":"grant","acquired":true,"shares":50000,"price":0.43,"value":21500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Open market acquisition."}],"balance_after":220244,"source":{"system":"sec-edgar","filing":"0001209191-22-054744","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919122054744/doc4.xml","form_type":"4"}},{"id":2168324,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-02T16:49:18.000Z","date":"2022-08-31","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One third of the aggregate amount of option shares shall vest on each of August 31, 2023, 2024 and 2025, respectively."}],"balance_after":75000,"derivative":{"exercise_price":1.13,"expiration_date":"2032-08-31","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-22-048523","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919122048523/doc4.xml","form_type":"4"}},{"id":2168323,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2022-09-02T16:49:18.000Z","date":"2022-08-31","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted on August 31, 2022. One hundred percent (100%) of the total number of RSUs granted vest on the earlier of (i) June 22, 2023 or (ii) the date of the Company's 2023 Annual Meeting of Stockholders."}],"balance_after":195244,"source":{"system":"sec-edgar","filing":"0001209191-22-048523","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919122048523/doc4.xml","form_type":"4"}},{"id":2399619,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2022-02-14T16:27:31.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":10000,"price":0.6849,"value":6849.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Open market acquisition."}],"balance_after":170244,"source":{"system":"sec-edgar","filing":"0001209191-22-009266","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919122009266/doc4.xml","form_type":"4"}},{"id":2659663,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-22T18:03:17.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":67804,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One third of the aggregate amount of option shares shall vest on each of June 17, 2022, 2023 and 2024, respectively."}],"balance_after":67804,"derivative":{"exercise_price":4.29,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":67804},"source":{"system":"sec-edgar","filing":"0001209191-21-042495","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919121042495/doc4.xml","form_type":"4"}},{"id":2659662,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2021-06-22T18:03:17.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":14277,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the restricted shares shall vest on the earlier of (1) June 17, 2022 or (2) the date of the company's 2022 Annual Meeting of Stockholders."}],"balance_after":160244,"source":{"system":"sec-edgar","filing":"0001209191-21-042495","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919121042495/doc4.xml","form_type":"4"}},{"id":2753487,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2021-04-08T14:26:28.000Z","date":"2021-04-07","kind":"grant","acquired":true,"shares":20000,"price":3.15,"value":63000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Open market acquisition."}],"balance_after":145967,"source":{"system":"sec-edgar","filing":"0001209191-21-026029","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919121026029/doc4.xml","form_type":"4"}},{"id":2852267,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2021-02-18T16:47:58.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":10000,"price":3.61,"value":36100.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Open market acquisition."}],"balance_after":125967,"source":{"system":"sec-edgar","filing":"0001209191-21-011890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919121011890/doc4.xml","form_type":"4"}},{"id":2932052,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2020-12-28T17:15:02.000Z","date":"2020-12-24","kind":"grant","acquired":true,"shares":10000,"price":3.79,"value":37900.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Open market acquisition."}],"balance_after":115967,"source":{"system":"sec-edgar","filing":"0001209191-20-065221","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919120065221/doc4.xml","form_type":"4"}},{"id":2985111,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2020-11-12T18:05:25.000Z","date":"2020-11-09","kind":"grant","acquired":true,"shares":10000,"price":3.78,"value":37800.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Open market acquisition."}],"balance_after":105967,"source":{"system":"sec-edgar","filing":"0001209191-20-058104","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919120058104/doc4.xml","form_type":"4"}},{"id":3029360,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2020-09-17T09:57:17.000Z","date":"2020-09-16","kind":"grant","acquired":true,"shares":1000,"price":4.2381,"value":4238.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Open market acquisition."}],"balance_after":95967,"source":{"system":"sec-edgar","filing":"0001209191-20-050793","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919120050793/doc4.xml","form_type":"4"}},{"id":3043185,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2020-09-01T15:49:33.000Z","date":"2020-08-28","kind":"grant","acquired":true,"shares":20000,"price":4.08,"value":81600.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Open market acquisition."}],"balance_after":94967,"source":{"system":"sec-edgar","filing":"0001209191-20-048887","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919120048887/doc4.xml","form_type":"4"}},{"id":3097112,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2020-06-30T16:10:46.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":8000,"price":3.21,"value":25680.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Open market acquisition."}],"balance_after":74967,"source":{"system":"sec-edgar","filing":"0001209191-20-039442","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919120039442/doc4.xml","form_type":"4"}},{"id":3104775,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-19T17:22:43.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One third of the aggregate amount of option shares shall vest on each of June 18, 2021, 2022 and 2023, respectively."}],"balance_after":60000,"derivative":{"exercise_price":2.94,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-20-037997","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919120037997/doc4.xml","form_type":"4"}},{"id":3104774,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2020-06-19T17:22:43.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the restricted shares shall vest on the earlier of (1) June 18, 2021 or (2) the date of the company's 2021 Annual Meeting of Stockholders."}],"balance_after":66967,"source":{"system":"sec-edgar","filing":"0001209191-20-037997","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919120037997/doc4.xml","form_type":"4"}},{"id":3148016,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2020-05-15T18:48:54.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":5000,"price":3.11,"value":15550.0,"ownership":{"direct":true},"balance_after":36967,"source":{"system":"sec-edgar","filing":"0001209191-20-029852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919120029852/doc4.xml","form_type":"4"}},{"id":3476120,"issuer":{"id":132524,"kind":"organization","name":"Odonate Therapeutics, Inc.","symbol":"ODT"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-28T20:03:09.000Z","date":"2019-06-26","kind":"purchase","acquired":true,"shares":19231,"price":26,"value":500006.0,"ownership":{"direct":true},"balance_after":23231,"source":{"system":"sec-edgar","filing":"0001209191-19-039462","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724161/000120919119039462/doc4.xml","form_type":"4"}},{"id":3481900,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-21T20:19:15.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the option shares vested on June 20, 2019.  The remaining option shares shall vest in 25% equal annual amounts on each anniversary date of the grant over three years."}],"balance_after":20000,"derivative":{"exercise_price":8.44,"expiration_date":"2029-06-20","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-19-038668","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919119038668/doc4.xml","form_type":"4"}},{"id":3481899,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2019-06-21T20:19:15.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the restricted shares shall vest on the earlier of (1) June 20, 2020 or (2) the date of the company's 2020 Annual Meeting of Stockholders."}],"balance_after":31967,"source":{"system":"sec-edgar","filing":"0001209191-19-038668","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919119038668/doc4.xml","form_type":"4"}},{"id":3528689,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2019-05-14T15:38:00.000Z","date":"2019-05-13","kind":"grant","acquired":true,"shares":1000,"price":8.93,"value":8930.0,"ownership":{"direct":true},"balance_after":21967,"source":{"system":"sec-edgar","filing":"0001209191-19-029584","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919119029584/doc4.xml","form_type":"4"}},{"id":3589232,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2019-03-19T13:41:45.000Z","date":"2019-03-18","kind":"grant","acquired":true,"shares":2000,"price":10.47,"value":20940.0,"ownership":{"direct":true},"balance_after":20967,"source":{"system":"sec-edgar","filing":"0001209191-19-020228","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919119020228/doc4.xml","form_type":"4"}},{"id":3591704,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2019-03-18T11:47:46.000Z","date":"2019-03-15","kind":"grant","acquired":true,"shares":2000,"price":9.62,"value":19240.0,"ownership":{"direct":true},"balance_after":18967,"source":{"system":"sec-edgar","filing":"0001209191-19-019902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919119019902/doc4.xml","form_type":"4"}},{"id":3606480,"issuer":{"id":132524,"kind":"organization","name":"Odonate Therapeutics, Inc.","symbol":"ODT"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-07T21:57:23.000Z","date":"2019-03-04","kind":"purchase","acquired":true,"shares":1000,"price":17,"value":17000.0,"ownership":{"direct":true},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-19-017812","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724161/000120919119017812/doc4.xml","form_type":"4"}},{"id":3606479,"issuer":{"id":132524,"kind":"organization","name":"Odonate Therapeutics, Inc.","symbol":"ODT"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-07T21:57:23.000Z","date":"2019-03-04","kind":"purchase","acquired":true,"shares":2000,"price":16.9999,"value":33999.8,"ownership":{"direct":true},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001209191-19-017812","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724161/000120919119017812/doc4.xml","form_type":"4"}},{"id":3709354,"issuer":{"id":132524,"kind":"organization","name":"Odonate Therapeutics, Inc.","symbol":"ODT"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-04T01:06:54.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest and become exercisable on December 31, 2019, subject to the Reporting Person's continued service to the Issuer through such date."}],"balance_after":12500,"derivative":{"exercise_price":14.08,"expiration_date":"2028-12-31","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-19-001518","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724161/000120919119001518/doc4.xml","form_type":"4"}},{"id":3746869,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-03T20:20:57.000Z","date":"2018-11-30","kind":"grant","acquired":true,"shares":14507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the option shares vested on November 30, 2018.  The remaining option shares shall vest in 25% equal annual amounts on each anniversary date of the grant over three years."}],"balance_after":14507,"derivative":{"exercise_price":14.02,"expiration_date":"2028-11-30","underlying":"Common Stock","underlying_shares":14507},"source":{"system":"sec-edgar","filing":"0001209191-18-060701","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919118060701/doc4.xml","form_type":"4"}},{"id":3746868,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2018-12-03T20:20:57.000Z","date":"2018-11-30","kind":"grant","acquired":true,"shares":6667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the restricted shares shall vest on June 19, 2019."}],"balance_after":16967,"source":{"system":"sec-edgar","filing":"0001209191-18-060701","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919118060701/doc4.xml","form_type":"4"}},{"id":4107744,"issuer":{"id":132524,"kind":"organization","name":"Odonate Therapeutics, Inc.","symbol":"ODT"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-05T01:52:56.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 12,500 shares of the Issuer's Common Stock, which shall be fully vested and exercisable on January 2, 2019."}],"balance_after":12500,"derivative":{"exercise_price":24.73,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-18-002269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724161/000120919118002269/doc4.xml","form_type":"4"}},{"id":4131907,"issuer":{"id":132524,"kind":"organization","name":"Odonate Therapeutics, Inc.","symbol":"ODT"},"owners":[{"id":23437,"kind":"person","name":"Vacirca Jeff L","position":1,"cik":"0001724161","reported_name":"Vacirca Jeff L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-15T01:01:02.000Z","date":"2017-12-12","kind":"purchase","acquired":true,"shares":1000,"price":23.3,"value":23300.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001209191-17-065777","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724161/000120919117065777/doc4.xml","form_type":"4"}}]}